Clinical Study | Office of Clinical Research

A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study Of Olaparib Maintenance Monotherapy In Patients With Brca Mutated Advance

Posted Date: May 15, 2019

Investigator: Eric Eisenhauer
Type of Study: Drug

You have been diagnosed with ovarian cancer, primary peritoneal cancer (the lining of the abdomen) or fallopian tube cancer. To participate in this study you will be tested for a specific type of genetic mutation in the BRCA genes. A mutation is a change in your deoxyribonucleic acid (DNA) which a

Criteria:

You Have Been Diagnosed With Ovarian Cancer, Primary Peritoneal Cancer (The Lining Of The Abdomen) O

Keywords:

Advanced, Brca, Gynecologyc Oncology, Maintenance, Ovarian Cancer

For More Information:

Kathy Amanns
513-584-4528
kathy.amanns@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List